We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Automated Inoculation System Provides Accurate Dosing of MIC Plates

By LabMedica International staff writers
Posted on 25 Jul 2011
An automated, inoculation delivery system provides faster, accurate dosing of minimum inhibitory concentration (MIC) plates for microbiology laboratories.

With a small-footprint and compact, user-friendly design, the Sensititre AIM automated inoculation delivery system is ideal for use directly on the benchtop or under a microbiology safety cabinet, providing flexible storage and accessibility and conserving valuable laboratory space. More...
It prevents missed wells and eliminates the need for repeat tests, improves laboratory workflow, and speeds results to clinicians.

The Sensititre AIM delivery system can be used with all Sensititre dried plates and quickly doses microtiter plates. The easy-to-use, icon-driven touch screen facilitates quick selection of dosing volumes and patterns for simple, intuitive operation.

TREK diagnostic systems' (Cleveland, OH, USA) Sensititre product line for susceptibility and identification testing enables labs to test US Food and Drug Administration (FDA; Silver Spring, MD, USA)-cleared antimicrobial drugs against a wide range of non-fastidious and fastidious bacteria and yeasts. This saves microbiology labs from having to use multiple off-line test procedures to obtain accurate susceptibility data.

The FDA cleared the TREK diagnostic systems-brand Sensititre AIM automated inoculation delivery system for in vitro diagnostics use in the United States. The AIM System has been used successfully in veterinary and pharmaceutical labs since its development. The AIM System is also CE-marked for sale outside the US.

Thermo Fisher Scientific Inc. (Waltham, MA, USA) has acquired TREK Diagnostic Systems, including blood culture, microorganism identification, and antibiotic susceptibility testing (AST) products, from Magellan Biosciences (Chelmsford, MA, USA). TREK Diagnostic Systems currently serves pharmaceutical and clinical laboratory markets and will be integrated into Thermo Fisher’s analytical technologies segment.

Related Links:

TREK diagnostic systems
US Food and Drug Administration
Thermo Fisher Scientific Inc.



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Automatic CLIA Analyzer
Shine i6000
Pipette Calibration System
Artel PCS®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport.... Read more

Molecular Diagnostics

view channel
Image: At the MHH Institute of Human Genetics: Prof. Dr. Doris Steinemann, Dr. Bernardus Aldrige Allister and Prof. Dr Monika Golas (from left). (Image Credit: Karin Kaiser/MHH)

Multi-Omics Analysis Identifies Additional Risk Genes in Hereditary Breast and Ovarian Cancer

Hereditary breast and ovarian cancer can be difficult to explain genetically, leaving many high-risk families without clear answers. Although 13 established risk genes, including BRCA1 and BRCA2, are routinely... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.